Cost-effectiveness of omalizumab in real world uncontrolled allergic asthma patients

Objective To estimate the cost-effectiveness of omalizumab compared with standard of care in the treatment and control of severe persistent asthma, using the outcomes from the Portuguese subpopulation of the eXpeRience registry.Methods This was a pragmatic cost-effectiveness analysis based on real w...

Full description

Saved in:
Bibliographic Details
Main Authors: A. Arrobas, M.P. Barbosa, S. Rabiais, B. Vandewalle, J. Félix
Format: Article
Language:English
Published: Taylor & Francis 2021-03-01
Series:Pulmonology
Subjects:
Online Access:https://www.tandfonline.com/doi/10.1016/j.pulmoe.2020.03.001
Tags: Add Tag
No Tags, Be the first to tag this record!